Danaher Corporation
204.85USD
-0.3800 (-0.19%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.92▼ | $2.02 | 0 | 3 |
| Next quarter | $2.58▲ | $2.52 | 5 | 0 |
| Current year | $8.51▲ | $8.44 | 3 | 3 |
| Next year | $9.3▲ | $9.09 | 3 | 5 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.84 | $1.94 | +0.10 (+5.3%) |
| 2026-03-31 | $1.94 | $2.06 | +0.12 (+6.5%) |
| 2025-12-31 | $2.19 | $2.23 | +0.04 (+2.0%) |
| 2025-09-30 | $1.72 | $1.89 | +0.17 (+9.8%) |
297 ratings from 42 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Equal-Weight | $212 $195 | Jul 22, 2026 |
| TD Cowen | Maintained | Buy | $240 $236 | Jul 22, 2026 |
| Stifel | Maintained | Buy | $260 $220 | Jul 22, 2026 |
| Guggenheim | Maintained | Buy | $235 $200 | Jul 22, 2026 |
| RBC Capital | Maintained | Outperform | $200 $215 | Jul 22, 2026 |
| Evercore ISI Group | Maintained | Outperform | $232 $230 | Jul 6, 2026 |
| Piper Sandler | Initiated | Neutral | $200 | Jun 11, 2026 |
| HSBC | Maintained | Buy | $270 $230 | Jun 3, 2026 |
| Citigroup | Downgraded from Buy | Neutral | $125 $95 | May 27, 2026 |
| Morgan Stanley | Maintained | Overweight | $270 $255 | Apr 23, 2026 |
| UBS | Maintained | Buy | $270 $250 | Apr 22, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $240 $212 | Apr 22, 2026 |
| Guggenheim | Maintained | Buy | $275 $235 | Apr 22, 2026 |
| Baird | Maintained | Outperform | $249 $245 | Apr 22, 2026 |
| Baird | Maintained | Outperform | $251 $249 | Apr 17, 2026 |
| Barclays | Maintained | Overweight | $250 $230 | Apr 14, 2026 |
| Goldman Sachs | Maintained | Buy | $265 $230 | Apr 13, 2026 |
| Evercore ISI Group | Maintained | Outperform | $254 $225 | Apr 6, 2026 |
| JP Morgan | Maintained | Overweight | $270 $275 | Jan 29, 2026 |
| Jefferies | Maintained | Buy | $255 $265 | Jan 29, 2026 |
| TD Cowen | Maintained | Buy | $260 $270 | Jan 7, 2026 |
| Guggenheim | Maintained | Buy | $250 $275 | Jan 5, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $230 $240 | Dec 15, 2025 |
| Goldman Sachs | Initiated | Buy | $265 | Dec 9, 2025 |
| Morgan Stanley | Initiated | Overweight | $270 | Dec 2, 2025 |
84 filings from 25 insiders · 16 buy / 2 sell over 6m
Officers and directors of DHR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| BLAIR RAINER MChief Executive Officer | Sellindirect | 58.3k | $217.77 | $12.74M | Aug 21, 2026 |
| RILEY CHRISTOPHER PAULOfficer | Grant | 41.1k | — | — | Aug 4, 2026 |
| GUTIERREZ-RAMOS JOSE-CARLOSOfficer | Grant | 13.5k | — | — | Aug 4, 2026 |
| MILOSEVICH GREGORY MOfficer | Grant | 15.4k | — | — | Aug 4, 2026 |
| RALES STEVEN MChairman of the Board | Grant | 500.0k | — | — | Aug 4, 2026 |
| RALES MITCHELL POfficer and Director | Grant | 500.0k | — | — | Aug 4, 2026 |
| ZERHOUNI ELIAS ADirector | Exercise | 3.3k | $71.88 | $237k | Jul 15, 2026 |
| FILLER LINDADirector | Exercise | 3.3k | $71.88 | $237k | Jul 15, 2026 |
| DEWAN FEROZDirector | Grant | 680 | — | — | May 15, 2026 |
| ZERHOUNI ELIAS ADirector | Grant | 680 | — | — | May 15, 2026 |
| LIST-STOLL TERI L.Director | Grant | 680 | — | — | May 15, 2026 |
| SANDERS A.SHANEDirector | Grant | 680 | — | — | May 15, 2026 |
| FILLER LINDADirector | Grant | 680 | — | — | May 15, 2026 |
| STEVENS RAYMOND CDirector | Grant | 680 | — | — | May 15, 2026 |
| LAMANNA CHARLES WDirector | Grant | 680 | — | — | May 15, 2026 |
| SPOON ALAN GDirector | Grant | 680 | — | — | May 15, 2026 |
| SPOON ALAN GDirector | Exercise | 3.3k | $71.88 | $237k | May 1, 2026 |
| SPOON ALAN GDirector | Sell | 1.4k | $174.67 | $237k | May 1, 2026 |
| LEIKEN JONATHAN BOfficer | Grant | 2.4k | — | — | Feb 27, 2026 |
| GRAY ROBERT BRADLEYOfficer | Grant | 2.8k | — | — | Feb 27, 2026 |
No analyst notes on DHR yet.
Analyst Ratings
23 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 17 | 4 | 0 | 0 | Buy1.96 |
| 1 mo ago | 5 | 17 | 4 | 0 | 0 | Buy1.96 |
| 2 mo ago | 5 | 17 | 4 | 0 | 0 | Buy1.96 |
| 3 mo ago | 4 | 18 | 4 | 0 | 0 | Buy2.00 |